Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment?
Costedoat-Chalumeau
Nathalie
N
Leroux
Gaelle
G
Piette
Jean-Charles
JC
Amoura
Zahir
Z
D018501:Antirheumatic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016903:Drug Monitoring; D006801:Humans; D006886:Hydroxychloroquine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D018570:Risk Assessment
D018501:Antirheumatic Agents; D006886:Hydroxychloroquine